These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 8982557)

  • 1. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of factors causing delayed graft function in live related donor renal transplantation.
    Sharma AK; Tolani SL; Rathi GL; Sharma P; Gupta H; Gupta R
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):242-5. PubMed ID: 20228507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.
    Gianello P; Carlier M; Jamart J; Hulhoven R; Bernheim J; Bernard A; Ketelslegers JM; Squifflet JP
    Clin Transplant; 1995 Dec; 9(6):481-9. PubMed ID: 8645892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the dialysis membrane in the treatment of patients with acute renal failure.
    Hakim RM; Wingard RL; Parker RA
    N Engl J Med; 1994 Nov; 331(20):1338-42. PubMed ID: 7935703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
    Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of rejection episodes during acute tubular necrosis--diagnosis and allograft outcome after cadaveric renal transplants].
    Hoshinaga K; Shiroki R; Kubota Y; Maruyama T; Higuchi T; Tsukiashi Y; Izumitani M; Horiba M; Naide Y
    Hinyokika Kiyo; 1998 May; 44(5):341-6. PubMed ID: 9656107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients.
    Schiffl H
    Nephrol Dial Transplant; 2006 May; 21(5):1248-52. PubMed ID: 16449291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts.
    Oda A; Morozumi K; Uchida K
    Clin Transplant; 1999; 13 Suppl 1():6-12. PubMed ID: 10751050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause of acute tubular necrosis affects its prognosis. The Auriculin Anaritide Acute Renal Failure Study Group.
    Weisberg LS; Allgren RL; Genter FC; Kurnik BR
    Arch Intern Med; 1997 Sep; 157(16):1833-8. PubMed ID: 9290542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible membranes do not promote graft recovery following cadaveric renal transplantation.
    Woo YM; Craig AM; King BB; Junor BJ; McMillan MA; Briggs JD; Rodger RS
    Clin Nephrol; 2002 Jan; 57(1):38-44. PubMed ID: 11841067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group.
    Adams MB
    Transplantation; 1992 Feb; 53(2):338-45. PubMed ID: 1738927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.